STOCK TITAN

Abacus Global Management SEC Filings

ABL Nasdaq

Welcome to our dedicated page for Abacus Global Management SEC filings (Ticker: ABL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Understanding Abacus Life Inc's (ABL) SEC filings gives investors visibility into the financial mechanics of a life settlements company. Unlike typical insurance companies, life settlement providers have unique disclosure requirements around policy portfolios, life expectancy assumptions, and premium payment obligations that drive their economics.

ABL's 10-K annual reports detail the company's policy acquisition activity, portfolio composition, and the actuarial assumptions underlying asset valuations. For life settlement investors, these disclosures reveal how management estimates remaining policy lifespans and calculates expected returns on acquired insurance contracts.

The company's 10-Q quarterly reports track policy purchases, premium expenses, and any realized gains from death benefits received during the period. These filings help investors monitor whether actual mortality experience aligns with the life expectancy estimates used in policy pricing.

8-K filings from Abacus Life announce material events including business developments, financial results, and significant corporate actions. The company has filed multiple 8-Ks disclosing material information relevant to shareholders following the stock.

Track Form 4 insider transactions to see when ABL executives and directors buy or sell company shares. Insider activity can signal management confidence in the company's outlook and policy portfolio performance.

Our AI-powered summaries help you quickly understand complex life settlement disclosures, including policy valuation methodologies and portfolio risk factors. Access ABL's complete SEC filing history with explanations that make specialized insurance terminology accessible.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
certification
-
Rhea-AI Summary

Abacus Global Management, Inc. has filed an amended shelf prospectus covering the resale of up to 9,302,765 shares of common stock and $64,380,575 aggregate principal amount of its 9.875% Fixed Rate Senior Notes due 2028 by selling securityholders. These securities were largely issued as consideration in the Carlisle and FCF asset management acquisitions, and Abacus will not receive any proceeds from their sale.

The Notes are senior unsecured obligations maturing on November 15, 2028, bearing interest of 9.875% per year, paid quarterly, with optional redemption by the company on or after February 15, 2027 and a change-of-control repurchase feature. Abacus operates through four divisions focused on life insurance settlements, alternative asset management, technology services, and data-driven wealth management, and has also issued $5 million of Series A Convertible Preferred Stock that ranks senior to common stock for dividends and liquidation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

Abacus Global Management, Inc. has filed a resale registration covering up to 9,513,736 shares of common stock and $64,651,200 aggregate principal amount of 9.875% senior notes due November 15, 2028. These securities may be sold from time to time by existing selling securityholders, and Abacus will not receive any proceeds from their sales, although it will pay registration expenses.

The notes are senior unsecured obligations bearing 9.875% interest, paid quarterly, and are redeemable by Abacus on or after February 15, 2027 at 100% of principal plus accrued interest. They are effectively subordinated to secured debt and structurally subordinated to liabilities of subsidiaries; as of September 30, 2025, Abacus reported approximately $409 million of indebtedness, including $149.25 million under a senior secured credit facility.

Abacus positions itself as a data-driven financial services firm focused on longevity-based assets, with four divisions spanning life settlements, asset management, technology services and wealth management, and has expanded through the Carlisle and FCF acquisitions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
Rhea-AI Summary

Abacus Global Management, Inc. (ABL) filed a current report to clarify details of its recently declared dividend. The company had previously announced a dividend of $0.20 on November 7, 2025, and is now reiterating that shareholders of record as of December 2, 2025 will be eligible to receive this dividend, which is scheduled to be paid on December 17, 2025. The updated information is provided through a new press release furnished as an exhibit, and the disclosure is made under Regulation FD to ensure all investors receive the same information at the same time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Abacus Global Management (ABL) announced two capital actions. The Board authorized a stock repurchase program for up to $10 million of common stock, commencing immediately and running through May 6, 2027. Repurchases may occur in the open market or privately negotiated transactions, including accelerated share repurchases, block trades, or pursuant to Rule 10b5-1 trading plans.

The Board also declared an annual cash dividend of $0.20 per share, payable on December 17, 2025 to shareholders of record as of December 2, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Abacus Global Management (ABL) reported a strong Q3 turnaround. Total revenue reached $62,975,156, up from $28,148,491 a year ago, as Life Solutions contributed $54,122,577 and asset management from related parties added $7,575,553. The company posted net income of $7,075,348 versus a prior-year loss of $5,284,811, with diluted EPS of $0.07 compared to a loss of $0.07. Year to date, revenue rose to $163,339,122 from $78,711,777, and operating income improved to $65,959,737.

Cash and cash equivalents were $86,418,953, and life settlement policies at fair value increased to $423,782,347. The balance sheet reflects higher current debt at fair value of $118,498,871 tied to fund redemption timing, while the warrant liability fell to $0 from $9,345,000. The quarter also included portfolio and platform expansion: the AccuQuote acquisition (non‑cash consideration of $9,265,197), completion of the NIB acquisition, and additional post‑close consideration for Carlisle. Shares issued and outstanding were 97,752,855 as of October 31, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

Abacus Global Management (ABL) furnished an update on its business, announcing results for the quarter ended September 30, 2025 and providing an investor presentation update.

Results were communicated via a press release attached as Exhibit 99.1, and the company plans to post a new investor presentation on its Investor Relations website. The disclosures under Items 2.02 and 7.01 are furnished and not deemed filed under the Exchange Act. The company notes it uses its website to share information that may be material to investors, consistent with Regulation FD.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

William H. McCauley Jr., Chief Financial Officer of Abacus Global Management, Inc., reported the vesting and acquisition of 283,333 shares of the issuer's common stock on July 3, 2025 following scheduled and modified restricted stock unit (RSU) awards. The Form 4 shows 0 cash paid for these shares and lists 795,000 shares beneficially owned after the transaction. The filing explains the 283,333-share vesting represents two-thirds of an October 27, 2023 RSU grant (including a March 27, 2025 modification) and details additional time-based RSUs that remain outstanding and will vest in future years, including grants from October 27, 2023; February 13, 2024; December 13, 2024; and April 2, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Abacus Global Management (ABL)?

The current stock price of Abacus Global Management (ABL) is $8.47 as of December 30, 2025.

What is the market cap of Abacus Global Management (ABL)?

The market cap of Abacus Global Management (ABL) is approximately 828.0M.
Abacus Global Management

Nasdaq:ABL

ABL Rankings

ABL Stock Data

827.97M
37.45M
58.53%
26.77%
4.63%
Insurance - Life
Investment Advice
Link
United States
ORLANDO